Transforming growth factor beta 1 and fibronectin messenger RNA in rat brain: responses to injury and cell-type localization

Neuroscience. 1993 Jun;54(4):893-907. doi: 10.1016/0306-4522(93)90583-2.

Abstract

Transforming growth factor-beta 1 rapidly increases in adult rat brain in response to experimental lesions. This study characterized the schedule of changes, regional distribution, and cellular localization of striatal transforming growth factor-beta 1 messenger RNA and fibronectin messenger RNA following partial striatal deafferentation by frontal cortex ablation. Frontal cortex ablation induced striatal transforming growth factor-beta 1 messenger RNA elevations that coincided temporally and overlapped anatomically with the course of degeneration of cortico-striatal afferent fibers. Within three days post-lesioning, transforming growth factor-beta 1 messenger RNA was localized at the cortical wound. By 10 days, the anatomical site of transforming growth factor-beta 1 messenger RNA expression shifted to the dorsal half of the deafferented striatum and co-localized with OX-42+ immunostained microglia-macrophage at the site of degenerating afferent terminals. Similarly, fibronectin messenger RNA also shifted from the cortical wound to the deafferented striatum by 10 days post-lesioning. Fibronectin messenger RNA was localized to glial fibrillary acidic protein+ immunostained astrocytes surrounding degenerating corticostriatal afferents. Infusion of transforming growth factor-beta 1 peptide elevated striatal and cortical fibronectin messenger RNA. These findings suggest that microglia-macrophage associated with degenerating afferent fibres can upregulate transforming growth factor-beta 1 messenger RNA and may influence fibronectin messenger RNA synthesis in reactive astrocytes. This study suggests that transforming growth factor-beta 1 has a role in controlling extracellular matrix synthesis following brain injury, which is analogous to that in peripheral wound healing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Astrocytes / metabolism
  • Autoradiography
  • Brain / cytology
  • Brain / drug effects
  • Brain / metabolism*
  • Brain Injuries / metabolism*
  • Cells, Cultured
  • Corpus Striatum / cytology
  • Corpus Striatum / drug effects
  • Corpus Striatum / metabolism
  • DNA / metabolism
  • Fibronectins / biosynthesis*
  • Glial Fibrillary Acidic Protein / immunology
  • Glial Fibrillary Acidic Protein / metabolism
  • Immunohistochemistry
  • In Situ Hybridization
  • Injections, Intraventricular
  • Male
  • Nerve Growth Factors / biosynthesis
  • Neurons, Afferent / drug effects
  • Neurons, Afferent / metabolism
  • RNA, Messenger / biosynthesis*
  • Rats
  • Rats, Inbred F344
  • Silver Staining
  • Transforming Growth Factor beta / biosynthesis*
  • Transforming Growth Factor beta / pharmacology

Substances

  • Fibronectins
  • Glial Fibrillary Acidic Protein
  • Nerve Growth Factors
  • RNA, Messenger
  • Transforming Growth Factor beta
  • DNA